Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Azabicyclo Compounds | 8 | 2018 | 91 | 3.66 | Why? |
| Ceftazidime | 8 | 2018 | 134 | 3.57 | Why? |
| Candida | 7 | 2019 | 425 | 2.67 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 7 | 2018 | 214 | 2.21 | Why? |
| Candidiasis, Invasive | 4 | 2019 | 107 | 1.92 | Why? |
| Candidemia | 5 | 2019 | 353 | 1.82 | Why? |
| Klebsiella pneumoniae | 5 | 2017 | 658 | 1.53 | Why? |
| beta-Lactamases | 5 | 2017 | 759 | 1.08 | Why? |
| Anti-Bacterial Agents | 14 | 2021 | 10083 | 1.00 | Why? |
| Antifungal Agents | 9 | 2020 | 1828 | 0.96 | Why? |
| beta-Lactamase Inhibitors | 3 | 2017 | 104 | 0.96 | Why? |
| Klebsiella Infections | 2 | 2017 | 466 | 0.93 | Why? |
| Bacterial Proteins | 5 | 2017 | 1318 | 0.90 | Why? |
| Drug Resistance, Multiple, Bacterial | 7 | 2018 | 1115 | 0.88 | Why? |
| Thienamycins | 2 | 2017 | 72 | 0.83 | Why? |
| Microbiological Techniques | 2 | 2019 | 232 | 0.83 | Why? |
| Magnetic Resonance Spectroscopy | 3 | 2018 | 881 | 0.73 | Why? |
| Candidiasis | 3 | 2018 | 334 | 0.72 | Why? |
| Bacteremia | 2 | 2018 | 1372 | 0.64 | Why? |
| Legionella pneumophila | 1 | 2017 | 143 | 0.63 | Why? |
| Colistin | 1 | 2018 | 217 | 0.61 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.60 | Why? |
| Microbial Sensitivity Tests | 10 | 2018 | 2886 | 0.60 | Why? |
| beta-Lactam Resistance | 1 | 2017 | 150 | 0.59 | Why? |
| Water Microbiology | 1 | 2017 | 248 | 0.59 | Why? |
| Drug Utilization | 1 | 2020 | 619 | 0.57 | Why? |
| Antimicrobial Stewardship | 2 | 2020 | 931 | 0.57 | Why? |
| Genome, Bacterial | 2 | 2017 | 446 | 0.54 | Why? |
| Echinocandins | 2 | 2017 | 139 | 0.53 | Why? |
| Drug Combinations | 8 | 2018 | 3852 | 0.49 | Why? |
| Lipopeptides | 2 | 2017 | 229 | 0.47 | Why? |
| Cephalosporins | 3 | 2018 | 250 | 0.43 | Why? |
| Equipment Contamination | 2 | 2019 | 1308 | 0.39 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.37 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.37 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.35 | Why? |
| Pulmonary Aspergillosis | 2 | 2021 | 408 | 0.29 | Why? |
| Invasive Pulmonary Aspergillosis | 2 | 2021 | 634 | 0.26 | Why? |
| Triazoles | 2 | 2018 | 440 | 0.26 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.26 | Why? |
| Molecular Diagnostic Techniques | 1 | 2019 | 4239 | 0.25 | Why? |
| Nitriles | 2 | 2018 | 1053 | 0.25 | Why? |
| Pseudomonas aeruginosa | 2 | 2018 | 652 | 0.24 | Why? |
| Pyridines | 2 | 2018 | 680 | 0.23 | Why? |
| Drug Resistance, Bacterial | 3 | 2021 | 1414 | 0.22 | Why? |
| Mucorales | 2 | 2019 | 92 | 0.22 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.22 | Why? |
| Porins | 2 | 2017 | 45 | 0.21 | Why? |
| Aspergillus | 2 | 2020 | 347 | 0.20 | Why? |
| Laundry Service, Hospital | 1 | 2019 | 10 | 0.20 | Why? |
| Bedding and Linens | 1 | 2019 | 53 | 0.19 | Why? |
| Blood Culture | 2 | 2018 | 308 | 0.19 | Why? |
| Pennsylvania | 2 | 2017 | 558 | 0.18 | Why? |
| Antibodies, Fungal | 1 | 2018 | 49 | 0.18 | Why? |
| DNA, Fungal | 1 | 2018 | 95 | 0.18 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.18 | Why? |
| Abdominal Abscess | 1 | 2017 | 41 | 0.17 | Why? |
| beta-Glucans | 1 | 2019 | 176 | 0.17 | Why? |
| Imipenem | 1 | 2017 | 57 | 0.17 | Why? |
| Penicillanic Acid | 1 | 2017 | 58 | 0.17 | Why? |
| Legionella | 1 | 2017 | 91 | 0.17 | Why? |
| Intraabdominal Infections | 1 | 2018 | 90 | 0.17 | Why? |
| Antigens, Fungal | 1 | 2018 | 106 | 0.17 | Why? |
| Carbapenems | 2 | 2017 | 343 | 0.17 | Why? |
| Sensitivity and Specificity | 4 | 2019 | 22971 | 0.16 | Why? |
| Legionnaires' Disease | 1 | 2017 | 108 | 0.16 | Why? |
| Drug Resistance, Microbial | 1 | 2020 | 419 | 0.15 | Why? |
| Candida albicans | 1 | 2017 | 217 | 0.15 | Why? |
| Hospitals, Veterans | 1 | 2017 | 229 | 0.15 | Why? |
| Drug Monitoring | 3 | 2018 | 1408 | 0.15 | Why? |
| Aspergillosis | 1 | 2018 | 264 | 0.14 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.14 | Why? |
| Mycological Typing Techniques | 1 | 2014 | 38 | 0.14 | Why? |
| Ceftriaxone | 1 | 2017 | 365 | 0.14 | Why? |
| Physicians, Primary Care | 1 | 2018 | 298 | 0.14 | Why? |
| Tacrolimus | 1 | 2017 | 435 | 0.14 | Why? |
| Clinical Decision-Making | 2 | 2018 | 3755 | 0.13 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.13 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.13 | Why? |
| Selection, Genetic | 1 | 2017 | 691 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Escherichia coli | 2 | 2017 | 1547 | 0.12 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.12 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.11 | Why? |
| Humans | 30 | 2021 | 930598 | 0.11 | Why? |
| Sodium Dodecyl Sulfate | 1 | 2009 | 14 | 0.11 | Why? |
| Benzenesulfonates | 1 | 2009 | 18 | 0.10 | Why? |
| Cell Wall | 1 | 2009 | 62 | 0.10 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.10 | Why? |
| Amino Acid Substitution | 1 | 2017 | 1706 | 0.10 | Why? |
| Immunosuppressive Agents | 2 | 2018 | 6331 | 0.10 | Why? |
| Mucormycosis | 1 | 2018 | 832 | 0.09 | Why? |
| Cell Adhesion | 1 | 2009 | 230 | 0.09 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.09 | Why? |
| Phagocytosis | 1 | 2009 | 409 | 0.09 | Why? |
| Microscopy, Electron, Transmission | 1 | 2009 | 605 | 0.08 | Why? |
| Prospective Studies | 4 | 2020 | 43301 | 0.08 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.08 | Why? |
| Microbial Viability | 1 | 2009 | 406 | 0.08 | Why? |
| Disinfection | 1 | 2019 | 2912 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.07 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.07 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.06 | Why? |
| Organ Transplantation | 1 | 2018 | 2616 | 0.06 | Why? |
| Male | 10 | 2018 | 367725 | 0.06 | Why? |
| Aged | 9 | 2021 | 215776 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Adult | 9 | 2021 | 244371 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.05 | Why? |
| Female | 10 | 2018 | 380317 | 0.05 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Retrospective Studies | 5 | 2018 | 105322 | 0.05 | Why? |
| Galactose | 1 | 2020 | 201 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Mannans | 1 | 2020 | 218 | 0.05 | Why? |
| Aged, 80 and over | 3 | 2018 | 88759 | 0.05 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2018 | 72 | 0.05 | Why? |
| Cells, Cultured | 1 | 2009 | 5835 | 0.04 | Why? |
| Amoxicillin | 1 | 2018 | 98 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2018 | 381 | 0.04 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2018 | 170 | 0.04 | Why? |
| Macrophages | 1 | 2009 | 2784 | 0.04 | Why? |
| Cytochrome P-450 CYP3A | 1 | 2017 | 88 | 0.04 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.04 | Why? |
| Epithelial Cells | 1 | 2009 | 3508 | 0.04 | Why? |
| Soft Tissue Infections | 1 | 2018 | 116 | 0.04 | Why? |
| Fluoroquinolones | 1 | 2018 | 235 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Clinical Studies as Topic | 1 | 2017 | 118 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Mutagenesis, Site-Directed | 1 | 2017 | 449 | 0.04 | Why? |
| Drug Resistance, Fungal | 1 | 2017 | 191 | 0.04 | Why? |
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2017 | 256 | 0.04 | Why? |
| Doxycycline | 1 | 2018 | 307 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Mice | 2 | 2017 | 21357 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Young Adult | 4 | 2018 | 93724 | 0.04 | Why? |
| United States Department of Veterans Affairs | 1 | 2018 | 553 | 0.03 | Why? |
| Nursing Homes | 2 | 2021 | 4155 | 0.03 | Why? |
| Cell Line | 1 | 2009 | 12040 | 0.03 | Why? |
| Textiles | 1 | 2019 | 458 | 0.03 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.03 | Why? |
| Nanotechnology | 1 | 2018 | 821 | 0.03 | Why? |
| Transplant Recipients | 2 | 2018 | 4982 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2018 | 23402 | 0.03 | Why? |
| Thoracic Surgery | 1 | 2018 | 623 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.02 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.02 | Why? |
| Lung Transplantation | 1 | 2017 | 1554 | 0.02 | Why? |
| Animals | 2 | 2017 | 78931 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Research | 1 | 2017 | 2115 | 0.02 | Why? |
| Leadership | 1 | 2017 | 2241 | 0.02 | Why? |
| Azithromycin | 1 | 2018 | 3943 | 0.02 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.01 | Why? |
| United States | 2 | 2019 | 46150 | 0.01 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.01 | Why? |
| Kidney Transplantation | 1 | 2017 | 5397 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.01 | Why? |
| Infection Control | 1 | 2019 | 23131 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |
Clancy's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(84)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_